-
Good Practice on the assessment of GMO-related aspects in the context of clinical trials with human cells genetically modified by means of viral vectors v5 15-09-2023 Good Practice on the assessment of GMO-related aspects in the context of clinical trials with human cells genetically modified by means of viral vectors v5 PDF | 471.66 kB
-
Common Application form for clinical research with human cells genetically modified by means of viral vectors v5 15-09-2023 Common Application form for clinical research with human cells genetically modified by means of viral vectors v5 DOCX | 30.3 kB
-
Common application form for viral vectors contained in investigational medicinal products for human use 01-11-2019 Common application form for viral vectors contained in investigational medicinal products for human use DOCX | 43.58 kB
-
Good Practice on the assessment of GMO related aspects in the context of clinical trials with AAV clinical vectors 01-11-2019 Good Practice on the assessment of GMO related aspects in the context of clinical trials with AAV clinical vectors PDF | 360.96 kB
-
Common application form for investigational medicinal products for human use that contain or consist of AAV vectors 01-11-2019 Common application form for investigational medicinal products for human use that contain or consist of AAV vectors DOCX | 36.54 kB
-
-
-
Aanvraagformulier deel A - Vereenvoudigde procedure naakt DNA 21-06-2018 Aanvraagformulier deel A - Vereenvoudigde procedure naakt DNA DOCX | 1.89 MB
-
Aanvraagformulier deel A - Reguliere procedure naakt DNA 21-06-2018 Aanvraagformulier deel A - Reguliere procedure naakt DNA DOCX | 663.35 kB
-
Aanvraagformulier deel A - Virale vector 21-06-2018 Aanvraagformulier deel A - Virale vector DOCX | 664.79 kB